Cryptolepis Supreme
Cryptolepis sanguinolenta (Cs) is a medicinal plant, indigenous to Western Africa. It has been used to treat malaria for generations. Besides being used as an antimalarial treatment, Cryptolepis sanguinolenta has been used in the USA to help those with Lyme disease (Borrelia burgdorferi), as well as it’s co-infections Bartonella, and Babesia. According to one study, the following herbs had the greatest inhibitory effect against Babesia duncani- Scutellaria Baicalensis (84%), Cryptolepis (80%), Japanese Knotweed (59%), and Artemisia Annua (58%) (1).
Cryptolepis also has the following properties, including: anti-inflammatory, antimicrobial, anti-amoebic, anti-cancer, and anti-malarial features (2-6). This herb is a very broad spectrum antimicrobial, similar to Melia and Golden Thread. It’s a popular herb for digestive disorders and infection, topically for skin infections, or orally for urinary tract.
Studies have shown it to be effective against the following bacteria: Staphylococcus saprophyticus, Staphylococcus aureus, Salmonella typhi, Proteus mirabilis, Escherichia coli, Proteus mirabilis, Pseudomonas aeruginosa, Klebsiella pneumonia.
Studies have also shown it to be effective against the following fungi: Candida albicans, Aspergillus niger, Microsporum canis, Epidermophyton floccosum, Trichophyton rubrum, Trichopyton mentagrophytes, and Saccharomyces cerevisiae.
Contraindications- Pregnancy and Nursing
Dosage 1-2 caps 3x/day
1. Zhang, Yumin, et al. "Botanical medicines Cryptolepis sanguinolenta, Artemisia annua, Scutellaria baicalensis, Polygonum cuspidatum, and Alchornea cordifolia demonstrate inhibitory activity against Babesia duncani." Frontiers in Cellular and Infection Microbiology 11 (2021): 624745.
2. Grellier, P.; Ramiaramanana, L.; Millerioux, V.; Deharo, E.; Schrével, J.; Frappier, F.; Trigalo, F.; Bodo, B.; Pousset, J.L. Antimalarial activity of cryptolepine and isocryptolepine, alkaloids isolated from Cryptolepis sanguinolenta. Phytother. Res. 1996, 10, 317–321. [Google Scholar] [CrossRef]
3. Tona, L.; Kambu, K.; Ngimbi, N.; Cimanga, K.; Vlietinck, A.J. Antiamoebic and phytochemical screening of some Congolese medicinal plants. J. Ethnopharmacol. 1998, 61, 57–65. [Google Scholar] [CrossRef] [PubMed]
4. Mills-Robertson, F.C.; Tay, S.C.; Duker-Eshun, G.; Walana, W.; Badu, K. In vitro antimicrobial activity of ethanolic fractions of Cryptolepis sanguinolenta. Ann. Clin. Microbiol. Antimicrob. 2012, 11, 16. [Google Scholar] [CrossRef] [Green Version]
5. Ansah, C.; Mensah, K.B. A review of the anticancer potential of the antimalarial herbal Cryptolepis sanguinolenta and its major alkaloid cryptolepine. Ghana Med. J. 2013, 47, 137–147. [Google Scholar]
6. Hanprasertpong, N.; Teekachunhatean, S.; Chaiwongsa, R.; Ongchai, S.; Kunanusorn, P.; Sangdee, C.; Panthong, A.; Bunteang, S.; Nathasaen, N.; Reutrakul, V. Analgesic, anti-inflammatory, and chondroprotective activities of Cryptolepis buchanani extract: In vitro and in vivo studies. BioMed. Res. Int. 2014, 2014, 978582
7. https://thesunlightexperiment.com/herb/cryptolepis